The peritoneovenous shunt: expectations and reality.
Moskovitz M.
Am J Gastroenterol. 1990 Aug;85(8):917-29.
PMID:2197858
Prognostic factors for peritoneovenous shunt placement for refractory ascites in liver cirrhosis.
Hamaguchi A, Ueda J, Taniai N, Yoshioka M, Matsushita A, Mizutani S, Kawano Y, Shimizu T, Kanda T, Murokawa T, Takata H, Furuki H, Aoki Y, Kawashima M, Irie T, Ono T, Haruna T, Yoshimori D, Yoshida H.
World J Gastroenterol. 2025 Dec 7;31(45):113848. doi: 10.3748/wjg.v31.i45.113848.
PMID:41378330
Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis.
Koyama S, Nogami A, Yoneda M, Cheng S, Koike Y, Takeuchi Y, Iwaki M, Kobayashi T, Saito S, Utsunomiya D, Nakajima A.
Tomography. 2024 Mar 25;10(4):471-479. doi: 10.3390/tomography10040036.
PMID:38668394
The influence of a peritoneovenous shunt for cirrhotic and malignant intractable ascites on renal function.
Segawa T, Kato K, Kawashima K, Suzuki T, Ehara S.
Acta Radiol Open. 2018 Mar 26;7(3):2058460118764208. doi: 10.1177/2058460118764208. eCollection 2018 Mar.
PMID:29623218
Peritoneovenous shunt scintigraphy to assess shunt patency in patients with refractory ascites.